Nanopath
Nanopath is a women’s health company developing point-of-care molecular diagnostics for pelvic and gynecologic infections. Its proprietary nanobiosensing technology provides highly specific molecular results in less than 20 minutes and has the capability to simultaneously detect tens to hundreds of pathogenic targets.
Company Ownership:
Woman Owned
Contact Name:
Alison Burklund
Contact Email:
Website:
https://nanopath.com/
City, State – Congressional District:
Lebanon,
NH
–
2
Technology:
Diagnostic
Funding:
Allergy and Infectious Diseases (NIAID)
NIH Projects:
NIH RePorter for
Nanopath
Sponsored Event(s):
Biotech Showcase | 2025
